Table 2.
Efficacy
| Best Response to Tisa-Cel | No Bridging (n = 17), n (%) | Bridging (n = 55), n (%) | Overall (n = 72), n (%) |
|---|---|---|---|
| Complete response (CR) | 5 (29.4) | 20 (36.4) | 25 (34.7) |
| Partial response (PR) | 4 (23.5) | 2 (3.6) | 6 (8.3) |
| Stable disease (SD) | 1 (5.9) | 3 (5.5) | 4 (5.6) |
| Progressive disease (PD) | 7 (41.2) | 30 (54.5) | 37 (51.4) |
|
| |||
| Vital Status at Last Observation | |||
|
| |||
| Alive | 12 (70.6) | 37 (67.3) | 49 (68.1) |
| Deceased | 5 (29.4) | 18 (32.7) | 23 (31.9) |